An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results.
from All Top News -- ScienceDaily https://ift.tt/2B2YFVQ
Here different kind of articles available for people, simple and easy tips related to different topics.
No comments:
Post a Comment